{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:42:58Z","timestamp":1774525378386,"version":"3.50.1"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.2169\/internalmedicine.4241-19","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:06:34Z","timestamp":1601417194000},"page":"611-615","source":"Crossref","is-referenced-by-count":12,"title":["Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma"],"prefix":"10.2169","volume":"60","author":[{"given":"Joe","family":"Okumoto","sequence":"first","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinjiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kakuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Horimasu","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyasu","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Fujitaka","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 24: 143-150, 2010.","DOI":"10.1016\/j.blre.2010.06.004"},{"key":"2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2016.10.010","volume":"102","author":"AM Chapman","year":"2016","unstructured":"2. Chapman AM, Sun KY, Ruestow P, Cowan DM, Madl AK. Lung cancer mutation profile of EGFR, ALK, and KRAS: meta-analysis and comparison of never and ever smokers. Lung Cancer 102: 122-134, 2016.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"3","unstructured":"3. Thai AA, Solomon BJ. Treatment of ALK-positive nonsmall cell lung cancer: recent advances. Curr Opin Oncol 30: 84-91, 2018."},{"key":"4","unstructured":"4. Open-label randomized PhaseIII Study of the Efficacy and Safety of CH5424802(AF802) in ALK-Positive Advanced or Recurrent Non-Small Cell Lung Cancer with Crizotinib control [Internet]. [cited 2019 Nov 19]. Available from: http:\/\/image.packageinsert.jp\/pdf.php?mode=1&yjcode=4291032M1029"},{"key":"5","unstructured":"5. Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician 69: 2599-2606, 2004."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Khan U, Ali F, Khurram MS, Zaka A, Hadid T. Immunotherapy-associated autoimmune hemolytic anemia. J Immunother Cancer 5: 15, 2017.","DOI":"10.1186\/s40425-017-0214-9"},{"key":"7","unstructured":"7. Michel M. Warm autoimmune hemolytic anemia: advances in pathophysiology and treatment. Presse Med 43: e97-e104, 2014."},{"key":"8","unstructured":"8. Barros MM, Blajchman MA, Bordin JO. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment. Transfus Med Rev 24: 195-210, 2010."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sakhri L, Mennecier B, Quoix A. Hemolytic anemia erlotinib treatment. Rev Pneumol Clin 69: 345-350, 2013.","DOI":"10.1016\/j.pneumo.2013.06.003"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. De Lavallade H, Khoder A, Hart M, et al. Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling. Blood 122: 227-238, 2013.","DOI":"10.1182\/blood-2012-11-465039"},{"key":"11","unstructured":"11. Anazawa R, Taniyama D, Kamata H, Miyamoto K, Sakamaki F. Two cases of rheumatoid arthritis after anticancer chemotherapy with pemetrexed for nonsmall-cell lung cancer. Ann Jpn Respir Soc 2: 269-273, 2013 (in Japanese, Abstract in English)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Schaer D, Geeganage S, Amaladas N, et al. The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapy. Clin Cancer Res 25: 7175-7188, 2019.","DOI":"10.1158\/1078-0432.CCR-19-0433"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takahashi T. Direct Antiglobulin test-negative autoimmune hemolytic anemia. Acta Haematol 140: 18-19, 2018.","DOI":"10.1159\/000489253"},{"key":"14","unstructured":"14. Kamesaki T. Diagnosis and treatment of hemolytic anemia. Rinsho Ketsueki (Jpn J Clin Hematol) 56: 1894-1902, 2015."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Garratty G. Immune hemolytic anemia associated with negative routine serology. Semin Hematol 42: 156-164, 2005.","DOI":"10.1053\/j.seminhematol.2005.04.005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kamesaki T, Oyamada T, Omine M, Ozawa K, Kajii E. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia. Am J Hematol 84: 98-101, 2009.","DOI":"10.1002\/ajh.21336"},{"key":"17","unstructured":"17. Parker V, Tormey CA. The direct antiglobulin test: indications, interpretation, and pitfalls. Arch Pathol Lab Med 141: 305-310, 2017."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kamesaki T. Autoimmune hemolytic anemia. Nihon Naika Gakkai Zasshi (J Jpn Soc Intern Med) 103: 1599-1608, 2014 (in Japanese).","DOI":"10.2169\/naika.103.1599"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_4241-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T03:46:50Z","timestamp":1613792810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_4241-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4241-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}